Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (PCS-2018C1-10621)
Received: 13 January 2021
Accepted: 28 January 2021
First Online: 5 March 2021
Ethics approval and consent to participate
: Ethical approval has been received from institutional review boards (IRBs) for all Toronto sites through Clinical Trials Ontario (1895), in Chapel Hill through UNC Biomedical IRB (19-1786), and in Chicago through NorthShore University HealthSystem IRB (EH18-129). Informed consent to participate is being obtained from all participants.
: Not applicable.
: The study team and all authors report no conflicts of interest. However, SNV reports royalties from UpToDate Inc. for authorship of materials related to depression and pregnancy. JJK is partly supported by a Small Business Innovation Research award from the National Institute of Mental Health (RS, PI). PR receives support from the Sinai Health System, Morgan Firestone Psychotherapy Chair. SD reports being a co-founder of Mindful Noggin, Inc. and receiving revenue from ExternalRef removed, receiving royalties from Guilford Press for books on Behavioral Activation and mindfulness. BHM receives financial support from the Labatt Family Chair in Biology of Depression in Late-Life Adults at the University of Toronto. He directly owns stocks of General Electric (less than $5000). Within the past 3 years, he has also received research support from Eli Lilly (medications for a NIH-funded clinical trial) and Pfizer (medications for a NIH-funded clinical trial). He has been an unpaid consultant to Myriad Neuroscience. AMS is a co-investigator for a Janssen Research and Development study, Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression.